Endpoints News Mar 31, 2026 PepGen’s muscle disease program posts poor mid-stage results as one patient's data get markedly worse
Endpoints News Mar 31, 2026 ViiV R&D head Kimberly Smith heads to retirement after three decades in HIV care
Endpoints News Mar 30, 2026 Samsung Bio union workers threaten strike over pay, disclosure of employee data
Endpoints News Mar 30, 2026 Post-Hoc Live: Will MAHA vaccine policies be a political problem for Republicans?
Endpoints News Mar 30, 2026 Viridian’s autoimmune eye disease shot passes Phase 3, but can it compete?
Endpoints News Mar 30, 2026 #ACC26: Kardigan's repeat dosing of blood pressure drug has no benefit over single shot
Endpoints News Mar 30, 2026 #AAD26: Sanofi reports underwhelming Phase 3 OX40 data in eczema, second case of Kaposi’s sarcoma
Endpoints News Mar 29, 2026 #ACC26: Merck leans toward lower Winrevair dose in Phase 3 trial for rare form of heart failure